Ashish Jha

Dean for Global Strategy

Harvard T.H. Chan School of Public Health

United States of America

OMB No. 0925-0001 and 0925-0002 (Rev. 09/17 Approved Through 03/31/2020) BIOGRAPHICAL SKETCH Provide the following information for the Senior/key personnel and other significant contributors. Follow this format for each person. DO NOT EXCEED FIVE PAGES. NAME: Ashish K. Jha eRA COMMONS USER NAME (credential, e.g., agency login): AJHA12 POSITION TITLE: K.T. Li Professor of Health Policy, Harvard T.H. Chan School of Public Health, Director, Harvard Global Health Institute; Professor of Medicine, Harvard Medical School EDUCATION/TRAINING (Begin with baccalaureate or other initial professional education, such as nursing, include postdoctoral training and residency training if applicable. Add/delete rows as necessary.) INSTITUTION AND LOCATION DEGREE Completion Date FIELD OF STUDY Columbia University, New York, NY B.A. 1992 Economics Harvard Medical School, Boston, MA M.D. 1997 Medicine Harvard School of Public Health M.P.H. 2004 Clinical Effectiveness A. Personal Statement I am a practicing physician, researcher, and Professor of Medicine at Harvard Medical School and the K.T. Li Professor of Global Health at the Harvard. T.H. Chan School of Public Health. As a researcher, my work has focused on four primary areas – (1) Public reporting, (2) Pay for performance and value-based care, (3) Health information technology, (4) Leadership – and the roles these play in effecting the delivery of safe, effective, patient-centered care. My research endeavors focus on improving the quality and costs of healthcare systems with a specialized focus on the impact of policies and improving health disparities. I have published over 200 empirical manuscripts on these topics. I am also a member of the National Academy of Medicine. Previously, I have also served as a Special Assistant to the VA Secretary General and have advised multiple governments in health policy and quality of care. B. Positions and Honors 1997-1998 Internship, Internal Medicine, University of California, San Francisco 1998-2000 Residency, Internal Medicine, University of California, San Francisco 2000-2001 Chief Residency, Internal Medicine, University of California, San Francisco 2002- Associate Physician, Brigham and Women’s Hospital, Boston, MA 2004- Staff Physician, VA Boston Healthcare System 2004- Assistant Professor of Health Policy, Harvard School of Public Health 2005- Assistant Professor of Medicine, Harvard Medical School 2007- Senior advisor for quality and safety, Veterans Health Administration, Washington, DC 2009-2012 Associate Professor of Health Policy, Harvard School of Public Health 2013- Professor of Health Policy, Harvard School of Public Health 2014- Director, Harvard Global Health Institute 2014- Professor of Medicine, Harvard Medical School 2017- Senior Associate Dean, Harvard T.H. Chan School of Public Health C. Contribution to Science 1. Disparities in Care: Disparities exist across many aspects of clinical care and can have a deleterious impact on the health outcomes of populations with social risk factors, such as race and ethnicity. In my work, I seek to understand the drivers of poor quality of care among vulnerable populations primarily using data derived from Medicare. a) Figueroa JF, Zheng J, Orav EJ, Epstein AM, Jha AK. Medicare Program Associated With Narrowing Hospital Readmission Disparities Between Black And White Patients. Health Affairs. 2018 April; 37(4):654-661. b) Joynt KE, Jha AK. Characteristics of hospitals receiving penalties under the Hospital Readmissions Reduction Program. JAMA. 2013 Jan 23; 309(4):342-3. PMID: 23340629. c) Jha AK, Orav EJ, Epstein AM. Low-quality, high-cost hospitals, mainly in South, care for sharply higher shares of elderly black, Hispanic, and medicaid patients. Health Aff (Millwood). 2011 Oct; 30(10):1904-11. PMID: 21976334. d) Jha AK, Epstein AM. Governance around quality of care at hospitals that disproportionately care for black patients. J Gen Intern Med. 2012 Mar; 27(3):297-303. PMID: 21948204; PMCID: PMC3286564. 2. Examining Quality of Care in U.S. This proposal requires an understanding of measuring quality of care in the U.S. I have substantial experience evaluating quality of care. a) Adler-Milstein J, Jha AK. HITECH Act Drove Large Gains in Hospital Electronic Health Record Adoption. Health Affairs (Milwood) 2017 Aug 1; 36(8): 1416-1422. b) Joynt KE, Harris Y, Orav EJ, Jha AK. Quality of Care and Patient Outcomes in Critical Access Rural Hospitals. JAMA 2011;306(1):45-52. c) Jha AK, Orav EJ, Zheng J, Epstein AM. Patients' Perception of Hospital Care in the United States. N Engl J Med 2008;359(18):1921-31. d) Burke LG, Frakt AB, Khullar D, Orav EJ, Jha AK. Association Between Teaching Status and Mortality in US Hospitals. JAMA 2017 May 23; 317(20): 2105-2113. 3. Examining Costs of Care: There is an increasing focus on reducing waste and controlling rising health care costs. I have worked on understanding drivers of high health spending in the U.S. and strategies to reduce unnecessary health care utilization. a) Figueroa JF, Joynt Maddox KE, Beaulieu N, Wild RC, Jha AK. Concentration of Potentially Preventable Spending Among High-Cost Medicare Subpopulations: An Observational Study. Ann Intern Med. 2017 Nov 21; 167(10):706-713. b) Papanicolas I, Woskie LR, Jha AK. Health Care Spending in the United States and Other High-Income Countries. JAMA 2018 March 13; 319(10): 1024-1039. c) Tsai TC, Jha AK. Surgical-readmission rates and quality of care. N Engl J Med. 2013 Dec 19; 369(25):2460-1. d) Figueroa JF, Lyon Z, Zhou X, Grabowski DC, Jha AK. Persistence and Drivers of High-Cost Status Among Dual-Eligible Medicare and Medicaid Beneficiaries: An Observational Study. Ann Intern Med. 2018 Oct 16; 169(8):528-534. 4. Evaluation of public reporting and value-based care: In recent years, there is a growing shift for transparency in health and also an increasing shift from paying for volume to paying for value. In my work, we have examined whether some national efforts are working, including accountable care organizations. a) Jha AK, Joynt KE, Orav EJ, Epstein AM. The Long-Term Effect of Premier Pay for Performance on Patient Outcomes. N Engl J Med 2012; 366:1606-1615. b) Figueroa JF, Tsugawa Y, Zheng J, Orav EJ, Jha AK. Association between the Value-Based Purchasing pay for performance program and patient mortality in US hospitals: observational study. BMJ. 2016 05 09; 353:i2214. c) Jha AK, Orav EJ, Epstein AM. Public reporting of discharge planning and rates of readmissions. N Engl J Med. 2009 Dec 31; 361(27):2637-45. d) Lee GM, Kleinman K, Soumerai SB, Tse A, Cole D, Fridkin SK, Horan T, Platt R, Gay C, Kassler W, Goldmann DA, Jernigan J, Jha AK. Effect of nonpayment for preventable infections in U.S. hospitals. N Engl J Med. 2012 Oct 11; 367(15):1428-37. My complete bibliography can be found at http://www.ncbi.nlm.nih.gov/pubmed/?term=Jha+AK. D. Research Support 76391 04/15/2019 – 04/14/2020 Robert Wood Johnson Foundation Developing a Research Agenda to Update Knowledge of the Social and Health-System Factors that Affect Health 2017-263684 The Bill and Melinda Gates Foundation 09/7/2017—06/30/2021 Towards Evidence-Based Health System Reform Role: Co-Investigator 2018-373679 Climate Change Solutions Fund 01/15/2018—01/14/2020 Association of Extreme Weather Events and Healthcare Spending 1R21MD011701-01 09/26/2017—05/31/2019 NIH/NIMHD Trends in Racial Disparities in Surgical Readmissions and Strategies to Narrow the Gap Role: Primary Investigator 20171084 The Commonwealth Fund 01/01/2018 – 06/30/2019 Using Segmentation and Data Analytics to Improve Care for High-Need, High-Cost Patients in ACOs Role: Primary Investigator 20181326 01/01/2018—05/31/2019 The Commonwealth Fund Managing High-Need, High-Cost Patients: An International Perspective Role: Primary Investigator 2017-0065 The John A. Hartford Foundation 07/01/2017 – 06/30/2019 Understanding Information Continuity and its Impact on Care for Older Adults Role: Primary Investigator Completed Research Support 20160620 The Commonwealth Fund 05/01/2016 – 10/31/2018 Understanding Who Becomes and Remains High-Cost/High Need Over Time: The Role of Mental Health and Social Factors Role: Primary Investigator 61569153-126906 07/01/2017—12/31/2017 Stanford Bright Spots in Care Deliver to High-Need, High-Cost Patients MED17P0035111 06/20/2015 – 09/30/2017 Medicare Payment Advisory Commission (MedPAC) Phase 2 of development of healthy days at home population-level quality measure Role: Primary Investigator 2014-0136 06/01/2015 – 10/31/2017 The John A. Hartford Foundation Understanding Health IT-Enabled Performance Improvement for Older Adults Role: Primary Investigator 6979247 07/01/2015 – 06/30/2017 Association of American Medical Colleges Understanding the Value of Academic Medical Centers Role: Primary Investigator 2015-EBO-310 06/01/2015 – 04/30/2016 The Rockefeller Foundation An Independent Panel on the Global Response to Ebola Role: Primary Investigator 15032 11/01/2014 – 08/31/2016 Peterson Center on Healthcare High Cost/High Risk Patients Role: Primary Investigator RX Foundation 01/01/2014 – 12/31/2015 The Impact of Insurance Expansion on Medicaid Patients Role: Primary Investigator 620140227 12/01/2013 – 04/30/2016 The Commonwealth Fund Care Utilization and Spending Patterns for High-Cost Medicare Role: Primary Investigator 12-04749 01/01/2013 – 05/31/2016 Blue Cross Blue Shield of Massachusetts Foundation Understanding High-Cost Patients in Massachusetts Role: Primary Investigator 1 R01 HL113567 04/01/2012 – 03/31/2016 NIH/National Heart, Lung, and Blood Institute Identifying Ways to Reduce Readmissions Among Minority-Serving U.S. Hospitals Role: Primary Investigator 1 R01 MD006230 04/01/2012 – 12/31/2016 NIH/NIMHD Understanding Disparities in Patient-Centered Hospital Care Role: Primary Investigator
DATE
TIME
SESSION
SESSION TITLE
1 FEB, 2020 15:30-17-30 hrs. PS 3.2 Artificial Intelligence and Digital Health: Opportunities and Risks